New Vaccine News
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial.
Topline interim data analysis from a Phase 3 ENSEMBLE clinical trial for an investigational single-dose #COVID19 vaccine candidate announced: http://bit.ly/3ck3LwX